Egbert Nitzsche
Overview
Explore the profile of Egbert Nitzsche including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Neubauer M, Nicolas G, Bauman A, Fani M, Nitzsche E, Afshar-Oromieh A, et al.
Eur J Nucl Med Mol Imaging
. 2023 Dec;
51(4):1185-1193.
PMID: 38038755
Purpose: To assess early tumor response with quantitated SPECT/CT and to correlate it with clinical outcome in metastatic castration-resistant prostate cancer (mCRPC) patients treated with Lutetium-PSMA I&T therapy. Methods: Single-center,...
2.
Berkmann S, Roethlisberger M, Mueller B, Christ-Crain M, Mariani L, Nitzsche E, et al.
Pituitary
. 2021 Jun;
24(6):878-886.
PMID: 34155554
Purpose: 11-C-methionine (MET)-positron emission tomography (PET) as an adjunct to magnetic resonance imaging (MRI) has been proposed as a suitable molecular imaging modality for localizing pituitary adenomas in Cushing's disease....
3.
Omlin A, Spahn M, Beyer J, Eberli D, Gillessen S, Jochum W, et al.
Praxis (Bern 1994)
. 2018 Sep;
107(19):1043-1051.
PMID: 30227804
No abstract available.
4.
Du Y, Carrio I, De Vincentis G, Fanti S, Ilhan H, Mommsen C, et al.
Eur J Nucl Med Mol Imaging
. 2017 Jun;
44(10):1671-1678.
PMID: 28631036
Purpose: Radium Ra 223 dichloride (radium-223, Xofigo®) is the first targeted alpha therapy for patients with castration-resistant prostate cancer and symptomatic bone metastases. Radium-223 provides a new treatment option for...
5.
Klaeser B, Nitzsche E, Schuller J, Koberle D, Widmer L, Balmer-Majno S, et al.
Onkologie
. 2009 Dec;
32(12):724-30.
PMID: 20016233
Background: Only responding patients benefit from preoperative therapy for locally advanced esophageal carcinoma. Early detection of non-responders may avoid futile treatment and delayed surgery. Patients And Methods: In a multi-center...
6.
Ghanem N, Altehoefer C, Hogerle S, Nitzsche E, Lohrmann C, Schafer O, et al.
Eur J Radiol
. 2005 Apr;
54(2):264-70.
PMID: 15837408
Purpose: We evaluated the diagnostic accuracy of magnetic resonance imaging (MRI) and positron emission tomography (PET) for detection of liver metastases in malignant melanoma. Material And Methods: Thirty-five patients with...
7.
Guller U, Nitzsche E, Moch H, Zuber M
J Natl Cancer Inst
. 2003 Jul;
95(14):1040-3.
PMID: 12865449
No abstract available.
8.
Hoegerle S, Nitzsche E, Altehoefer C, Ghanem N, Manz T, Brink I, et al.
Radiology
. 2002 Jan;
222(2):507-12.
PMID: 11818620
Purpose: To evaluate fluorine 18 ((18)F) dihydroxyphenylalanine (DOPA) whole-body positron emission tomography (PET) as a biochemical imaging approach for detection of pheochromocytomas. Materials And Methods: (18)F DOPA PET and magnetic...